{"sourcedb":"DevicePMAs@therightstef","sourceid":"P950034_S037","text":"Approval for the addition of a quarter sheet configuration to the seprafilm adhesion barrier product line.  The device, as modified, will be marketed under the trade name seprafilm 4-section and is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.","project":"consensus_PMA_Age_Indications"}